Diabetes technology

Hybrid Closed-Loop Therapy in Adults with Type 1 Diabetes in England: Long-Term Outcomes from a Real-World Observational Study

Diabetes Technol TherPublished Real-world observational study

Authors' conclusion

Long-term real-world use of HCL is associated with sustained improvements in glycemic and person-reported outcomes in adults with type 1 diabetes and above-target HbA1c levels.

Study context

Population
Adults with T1D on insulin pump and isCGM with hemoglobin A1c (HbA1c) ≥8.5% (69 mmol/mol), started on hybrid closed loop (HCL) Aug–Dec 2021 in the NHS England HCL pilot, 30 UK diabetes centres; median age 40 years, 68% female, 85% White British
Participants
420 adults30 diabetes centres
Exposure
HCL follow-up vs baseline
  • HCLn = 420
Outcome
Change in mean adjusted HbA1c
Follow-up
Median 12 months (IQR 8-28) (range 6-38 months)
Methodological detailslongitudinal, multicentre
  • Longitudinal
  • Multicentre

Main finding

As reported in the abstract

Mean adjusted HbA1c reduction, %

1.4%

95% CI −1.5, −1.3P < 0.001

Mean adjusted HbA1c reduction, mmol/mol

16 mmol/mol

95% CI −17, −14P < 0.001

Observational data: associations, not effects.

Further findings

TIR (70-180mg/dL)

TIR increased from 33.7% to 60.4% (P < 0.001)

Proportion achieving HbA1c ≤7.5% (58 mmol/mol)

Proportion increased from 0% to 33.1% (P < 0.001)

Diabetes distress score

Diabetes distress score reduced
−1.1 (95% CI −1.3, −1.0; P < 0.001)

Gold score (hypoglycemia awareness)

Gold score reduced
−0.4 (95% CI −0.5, −0.2; P < 0.001)

Impaired hypoglycemia awareness (Gold score ≥4)

Percentage decreased, baseline vs follow-up (P < 0.001)
16.6% vs. 9.2%

Positive impact of HCL on quality of life (user opinion)

Participants stating HCL had a positive impact on quality of life
94.5%; 361/382

Hospital admissions

The number of hospital admissions was low

Safety

The number of hospital admissions was low

Original publication

Hybrid Closed-Loop Therapy in Adults with Type 1 Diabetes in England: Long-Term Outcomes from a Real-World Observational Study. Diabetes Technol Ther. Published 30 May 2025. doi:10.1089/dia.2025.0165

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.